MiMedx Group News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

23.04.18	MiMedx to Highlight Efficacy of Its Allografts in Presentations at SAWC Spring Conference (PR Newswire)
28.03.18	MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of RMAT Designated AmnioFix® Injectable For The Treatment Of Osteoarthritis Of The Knee (PR Newswire)
26.03.18	MiMedx To Participate In The Needham Healthcare Conference (PR Newswire)
26.03.18	MiMedx Reports Positive Pain And Foot Function Results From Phase 2B Clinical Trial Of AmnioFix® Injectable In The Treatment Of Plantar Fasciitis (PR Newswire)
21.03.18	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MiMedx Group, Inc. of Class Action Lawsuit and Upcoming Deadline -- MDXG (PR Newswire)
16.03.18	MIMEDX GROUP LEAD PLAINTIFF ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In MiMedx Group, Inc. To Contact The Firm (PR Newswire)
15.03.18	MiMedx Announces Expectation to Exceed the $92 Million Top End of First Quarter Revenue Guidance (PR Newswire)
12.03.18	SVRA Disappoints, SNY/REGN's Praluent Price To Be Cut, OBSV On Watch (RTTNews)
09.03.18	AmnioFix® Injectable Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the FDA for the Treatment of Osteoarthritis of the Knee (PR Newswire)
07.03.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against MiMedx Group, Inc. (MDXG) & Lead Plaintiff Deadline: April 25, 2018 (PR Newswire)
02.03.18	MiMedx Receives Notice of Filing Delinquency from NASDAQ (PR Newswire)
24.02.18	Block & Leviton LLP Announces It Has Filed A Class Action Against MiMedx Group, Inc. (MDXG) (PR Newswire)
23.02.18	MiMedx: A Different Kind Of Graft? (RTTNews)
22.02.18	Scott+Scott, Attorneys at Law, LLP Announces Investigation into MiMedx Group Inc. (MDXG) (PR Newswire)
21.02.18	MiMedx to Host Conference Call on February 23, 2018 at 10:30 AM Eastern Time (PR Newswire)
21.02.18	MiMedx Group, Inc. Shareholder Alert -- MDXG Stock Drops Significantly -- Kehoe Law Firm, P.C. Investigating (PR Newswire)
20.02.18	RM LAW Announces Investigation of MiMedx Group, Inc. (PR Newswire)
20.02.18	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG (PR Newswire)
20.02.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of MiMedx Group, Inc. (MDXG) (PR Newswire)
20.02.18	MIMEDX GROUP INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In MiMedx Group, Inc. To Contact The Firm (PR Newswire)
20.02.18	Wolf Popper LLP Announces Investigation on Behalf of Investors in MiMedx Group, Inc. (PR Newswire)
20.02.18	Block & Leviton LLP Investigates MiMedx Group, Inc. (MDXG) Following Internal Investigation Over Accounting Practices (PR Newswire)
20.02.18	MiMedx Postpones Release of its Fourth Quarter and Fiscal Year 2017 Financial Results (PR Newswire)
25.01.18	MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Sellers (PR Newswire)
24.01.18	Covisum Provides New Resources to Help Financial Advisors Navigate the Tax Cuts and Jobs Act (PR Newswire)
17.01.18	MiMedx Announces the Enrollment of the First Patients in the Phase 3 Clinical Trial of AmnioFix® Injectable for Achilles Tendonitis (PR Newswire)
17.01.18	EIGR Disappoints, EXEL's CELESTIAL Excels, JUNO In CELG's Crosshairs? (RTTNews)
16.01.18	MiMedx Announces First Patients Have Been Enrolled In The Phase 3 Clinical Trial Of AmnioFix® Injectable In Patients With Recalcitrant Plantar Fasciitis Pain (PR Newswire)
13.01.18	Mimedx To Host Shareholder Call On January 18, 2018 To Update Progress On Multiple Clinical Studies And Status Of Patent Portfolio (PR Newswire)
08.01.18	CELG Makes Blockbuster Purchase, MDXG, NBIX On Watch, Busy Year Ahead For ALNY (RTTNews)
07.01.18	MiMedx Releases Preliminary 2017 Revenue of $324.5 Million representing a 32% increase over 2016 (PR Newswire)
06.01.18	MiMedx Provides Update On Illegal Short Selling Activities Against The Company (PR Newswire)
20.12.17	4WD Supacentre Announces Launch of Brand-New Range of Adventure Kings Portable Ice Boxes (PR Newswire)
15.12.17	MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Sellers (PR Newswire)
13.12.17	MiMedx Forecasts 2018 Revenue To Be In The Range Of $383 Million To $387 Million (PR Newswire)
12.12.17	MiMedx Announces Release Of 2018 Guidance And Shareholder Conference Call (PR Newswire)
06.12.17	Two Independent Poster Abstracts Highlighting The Clinical Efficacy of MiMedx Allografts are Recognized at The 2017 Desert Foot Conference (PR Newswire)
30.11.17	MiMedx Issues Shareholder Letter Detailing The Illegal Short Selling The Company Is Experiencing (PR Newswire)
30.11.17	MiMedx Announces Expectation To Exceed Top End of Fourth Quarter Revenue Guidance Of $88 Million (PR Newswire)
21.11.17	MiMedx to Present at the 29th Annual Piper Jaffray Healthcare Conference (PR Newswire)
21.11.17	MiMedx Provides Update On Its Reimbursement Coverage (PR Newswire)
20.11.17	MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Sellers (PR Newswire)
17.11.17	MiMedx Market Leadership Well Positioned In Light Of FDA New Guidance Document (PR Newswire)
14.11.17	MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Sellers (PR Newswire)
08.11.17	MiMedx To Webcast Its Investor's Day Conference on November 30, 2017 (PR Newswire)
08.11.17	MiMedx to Present at Jefferies 2017 London Healthcare Conference (PR Newswire)
02.11.17	MiMedx To Present At The Canaccord\|Genuity Medical Technology And Diagnostics Forum (PR Newswire)
30.10.17	MiMedx Group Investor Reminder and Update: Hagens Berman Reminds MiMedx Group Investors of Investigation into Possible Securities Law Violations Related to Report Questioning MiMedx's Accounting... (PR Newswire)
30.10.17	MiMedx CEO Replies to Fraudulent Information About The Company (PR Newswire)
27.10.17	MiMedx Exposes Content of a Short Seller Website Dedicated to Posting Defamatory and False Information About The Company (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu MiMedx Group Inc

Aktien Top/Flop

Meistgelesene Nachrichten